(a) Inhibits autocrine or paracrine pathways; (b) decreases tumor cyclin D3, cyclin E, and cyclin B expression; (c) inhibits AMPK/mTOR pathway signaling in NSCLC cells. This evidence concerns the gene MTOR and non-small cell lung carcinoma.